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Abstract 
 
Every patient with pain has the right to be treated with dignity, respect, and high quality 
pain management. This study aimed to investigate the level of knowledge and attitudes of 
health care providers (HCPs) regarding medicating pregnant women with chronic pain at 
the governmental Hospitals in the Gaza Strip. Observational descriptive cross-sectional 
study design was used. A simple random sampling technique was used, by Epi Infer version 
7, 144 HCPs were selected from target population 340 HCPs who were working at the 
obstetric departments 136 HCPs out of 144 HCPs with a response rate 94.4%. A validated 
questionnaire as a study tool was used. Different statistical procedures operated by SPSS 
version 20 were used for data analysis including percentages, mean, independent sample t 
test, and One-way ANOVA. The study results revealed that the mean percentage of 
knowledge of HCPs to medicate pregnant women with chronic pain is 55.14%, mean of 
their attitude is 36.33%. The results revealed that there were no statistically significant 
differences in the level of HCPs' knowledge and attitudes with regard to their gender, 
educational levels, job titles, years of experience, and places of work. While there were 
significant differences in the mean level of HCPs‘ knowledge with regard to their age 
groups in favor of those who are more than 40 years. Also, there were statistically 
significant differences in the mean level of HCPs‘ knowledge among their different years of 
experience in favor of those who have more than 15 years of experience. Moreover, there 
were statistically significant differences in the mean level of HCPs‘ knowledge among their 
different places of work in favor of those who are working at Al Aqsa Hospital. The study 
concluded that HCPs in the obstetrical departments in the Gaza Strip have adequate 
knowledge and attitude regarding medicating pregnant women with chronic pain. The 
researcher recommends conducting periodic educational sessions for all types of HCPs to 
receive more important information about chronic pain management especially for pregnant 
women. 
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Chapter 1: Introduction 
1.1 Background 
Pain is an unpleasant sensory and emotional experience associated with actual or potential 
tissue damage (International Association for the Study of Pain, 2011). The American Pain 
Society (2010) supports efforts to improve pain management for patients in all healthcare 
settings. The Joint commission implemented standards in 2000 requiring healthcare 
professionals to recognize the right of patients to have appropriate assessment and 
management of pain. All patients must be screened for pain on admission and re-assessed 
as clinically required throughout the hospital stay (The Joint Commission, 2015).  
Thus for effective pain management HCPs must be well-educated and knowledgeable 
about pain. This begins with a thorough and accurate assessment of patient's pain (Nuseir 
et al., 2016). Nurses and other health care providers play a pivotal role in the assessment, 
relief, and evaluation of pain. Pregnant women experience moderate to severe pain related 
to some causes during pregnancy. This pain if managed ineffectively, can lead to negative 
physiological and psychological ramifications including the development of chronic pain 
syndromes (D‘Arcy, 2011). Optimal pain relief is reliant on health care providers‘ 
knowledge and understanding; systematic and consistent assessment; and regular 
documentation of pain (Francis & Fitzpatrick, 2013).  
However, there are some barriers in chronic pain management among nurses, including 
knowledge deficits regarding pain assessment and management principles, failure to assess 
and acknowledge the existence of pain, and communication difficulties between the patient 
and the nurse (Pasero, 2009).  
A thorough pain assessment is vital in the management of pain and should be priority in 
the care and treatment. The Joint Commission developed pain management standards that 
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require providers to recognize the rights of patients by appropriately assessing and 
managing their pain. Patients are to be screened for pain during their initial assessment, 
when clinically required, and during ongoing reassessments. In addition, patients are to 
receive education about pain management (The Joint Commission, 2012). 
1.2 Research problem 
Non-obstetrical causes of pain during pregnancy are very common and can be 
incapacitating if not treated appropriately. A recent study, with a cohort of more than 
500,000 pregnant women in the United States, found that 14% of women filled a 
prescription for an opioid at least once during the antepartum period and 6% of women 
received opioids throughout all trimesters (Bateman et al., 2014), unfortunately; data from 
Palestine are not available. Additionally, Desai et al. (2014) found that more than one 
million pregnant women found that prescription opioids were dispensed to approximately 
one out of five women during pregnancy. Pain continues to be inadequately treated by 
healthcare providers due to a combination of inadequate knowledge about pain, negative 
attitudes, poor ability to assess pain, fear of patient addiction, and restrictive regulation of 
controlled substances (Zuccaro et al., 2012). 
Chronic pain has significant problems to the pregnant woman, in which it triggers the 
woman‘s body‘s stress response which causes the release of catecholamine and cortisol. 
Also, it makes an increase in the heart rate and respiration, blood is shunted away from 
non-vital organs and makes depression in the immune system as well (Mellin, 2016). 
Moreover, chronic pain attached with pregnant woman can cause reduced mobility, anxiety 
and depression, loss of muscle strength, impaired sleep, increased susceptibility to disease, 
and potential dependence on medication, thus the overall health of the fetus will be in 
danger (Brennan, et al., 2007).  
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Moreover, if the pregnant woman has chronic pain during pregnancy, it can lead to 
changes in the function of the nervous system which lead to decrease inhibition of pain 
sensation (Grieve & Schultewolter, 2014). This may lead to multiple mechanisms of pain 
which will require multiple medications. If all the components of pain are not treated 
adequately, the pain will persist (Grieve and Schultewolter, 2014). 
The concept of pain management in the Gaza Strip (GS), especially among pregnant 
women; is not adequately practiced. However, the HCPs are dedicated to the provision of 
comfort and alleviation of suffering, the HCPs‘ role in chronic pain management in general 
and among pregnant women still vague in Palestine, this is may be caused by some factors 
including lack of knowledge regarding this issue and the presence of barriers which 
hamper the application of this concept.  
1.3 Justification of the study 
Globally, it has been reported that there is a high incidence rate of pain syndromes during 
pregnancy, and it was noted that there was increasing in the use of narcotics for pain 
management through the antepartum period (Shah et al., 2015). Also, since the death from 
opioid pain relievers has increased fivefold since 2010; it is important to study the 
knowledge of the health care providers (HCPs) toward chronic pain management at the 
governmental hospitals in the GS to reveal if the pregnant women are adequately 
medicated or not. Since there are no available data in Palestine regarding chronic pain 
management especially among pregnant women, and up to the researcher‘s knowledge this 
the first study to investigate the knowledge of HCPs regarding chronic pain management; 
the results  of this study may generate information which can be used for evidence based 
practice in future for effective pain management. 
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The results which will be obtained from this study might reveal some important facts 
regarding testing the knowledge about the lack of chronic pain management among HCPs; 
the issue which may alter their management process and might affect the general status of 
pregnant women with chronic pain. This study provided evidence about HCPs‘ attitudes 
toward pain management for pregnant women. Also, the investigation of the level of HCPs' 
knowledge and attitude regarding chronic pain management at the governmental hospitals 
in the GS, may help give solutions and suggestions for policy makers at the ministry of 
health (MoH) to work seriously to raise the knowledge level in pain management among 
HCPs.. 
1.4 Main aim of the study 
The main aim of this study is to investigate the level of knowledge and attitudes of health 
care providers regarding medicating pregnant women with chronic pain at the 
governmental hospitals in the Gaza Strip. 
1.5 Specific objectives of the study 
1. To identify the level of health care providers‘ knowledge of medicating pregnant 
women with chronic pain at the governmental hospitals in the Gaza Strip. 
2. To identify the level of health care providers‘ attitudes of medicating pregnant 
women with chronic pain at the governmental hospitals in the Gaza Strip. 
3. To explore the differences in the health care providers‘ knowledge and attitudes of 
medicating pregnant women with chronic pain with regard to their demographic 
factors. 
4. To set specific recommendations for policy makers at the ministry of health in 
order to improve the knowledge of health care providers regarding medicating 
pregnant women with chronic pain. 
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1.6 Research questions 
1. What is the level of health care providers‘ knowledge and attitudes of medicating 
pregnant women with chronic pain at the governmental hospitals in the Gaza Strip? 
2. What is the level of health care providers‘ attitudes of medicating pregnant women 
with chronic pain? 
3. Is there significant difference in the knowledge and attitudes of medicating 
pregnant women with chronic pain between male and female health care providers? 
4. Is there significant difference in the knowledge and attitudes of medicating 
pregnant women with chronic pain among different age groups of health care 
providers? 
5. Is there significant difference in the knowledge and attitudes of medicating 
pregnant women with chronic pain among different job titles of health care 
providers? 
6. Is there significant difference in the knowledge and attitudes of medicating 
pregnant women with chronic pain among different years of experience of health 
care providers? 
7. Is there significant difference in the knowledge and attitudes of medicating 
pregnant women with chronic pain among different working settings of health care 
providers? 
8. Is there significant difference in the knowledge and attitudes of medicating 
pregnant women with chronic pain among different educational qualifications of 
health care providers? 
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1.7 Operational definitions of terms 
1.7.1 Knowledge of medicating pregnant woman chronic pain 
The researcher defined knowledge as the ―knowledge score of the health care providers 
about the information regarding pregnant women with chronic pain based on the scale that 
will be provided in this study. Health care providers will be granted a score of ―one‖ for a 
correct answer on the questionnaire. 
1.7.2Attitude of medicating pregnant woman chronic pain 
The researcher defined attitude in this study as the degree to which the health care 
providers have a favorable or unfavorable evaluation of the pregnant woman with chronic 
pain. A score of ―one‖ for a correct answer will be identified as positive attitude. 
1.7.3 Pregnant women 
The researcher defined ―pregnant women‖ in this study as whom who are attending the 
governmental hospitals in the Gaza Strip.   
1.7.4 Health care providers  
The researcher defined health care providers as health care professional such as physicians, 
nurses, and pharmacists who are engaged in the process of health care of the pregnant 
women. 
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1.8 Demography and population 
1.8.1 Gaza Strip    
The Gaza Strip is a highly crowded area, where approximately 2 million residents live on 
365 km
2
. According to MoH annual report 2013, the total number of Palestinian people 
estimate was 4.485.459 of which, 2.278.562 were males and 2.206897 were females. Gaza 
Strip has a population of 2,000,000 people. The age and sex distribution of population in 
Palestine showed that 43.3% of Palestinian people were less than 15 years old. The age 
group (0-4 years) was 16.6%, while ages over 65 years constituted only 2.2%, so 
Palestinian society is described as a young population (Palestinian central Bureau of 
Statistics ―PCBS‖, 2016). 
1.8.2 Palestinian health care system 
The health care system in Palestine is complex and unique and strongly influenced under 
the so-called Israeli occupation. The consequences of the closures and separation imposed 
a great challenge for the ministry of health by creating obstacles regarding the accessibility 
to health care services and affected the unity of the health care system in all Palestinian 
governorates. There are five main health care providers: the ministry of health, united 
nations relief and work agency for Palestine refugees in the near east (UNRWA), non-
governmental organizations (NGOs), Palestinian military medical services and the private 
sector 2013 (MoH, 2015). 
1.8.2.1 Ministry of health 
Ministry of health bears the heaviest burden as it has the responsibility for ensuring 
equitable and affordable access to quality health services for all Palestinians. There are 54 
primary health care centers in Gaza Strip and 404 centers in West Bank. The hospital 
services are operated by the government and non-government sectors. According to the 
MoH in 2012 there were 81 hospitals in Palestine; 51 in West Bank and 30 in the Gaza 
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Strip with a total number of 2399 beds in government hospitals (1.4 bed / inhabitant); 
58.4% in WB and 51.6% in GS (MoH, 2016). 
Nasser Medical Complex (NMC), contain two hospitals: Nasser (medical and surgery) and 
Altahreer hospital (obstetrics and women, and children), the clinical capacity is a total of 
258 beds. Altahreer hospital has two pediatric departments with capacity of 50 beds. The 
complex is situated in the western area of Khan Younis, which was built in 1958 on an area 
of 50000 m2, and serves the area of Khan Younis, with a population of 270,979 inhabitants 
(MoH, 2016). 
Al Aqsa Martyrs Hospital  provides medical, surgical, pediatric, and gyna and obstetrics 
services, the clinical capacity is about 103 bed, located in the middle governorate of Deir 
Al-Balah, it has been built in 2001 on an area of 4000 m
2
, serves the segment of the 
population living in the central Gaza governorate with a population of 205,535. The 
hospital has a paediatric department with a capacity of 40 beds (MoH, 2016). 
Al Shifa is a medical complex includes three hospitals: the surgery hospital, medical, 
obstetrics and Gyna hospital, the clinical capacity is a total of 500 beds. It is located in the 
central west of Gaza City, it was built in 1946 on an area of 42000 m
2
, and serves the area 
of coverage of the Gaza province with a population of 496,411 people in particular, and the 
Gaza Strip in general, has ten operating rooms. Obstetrics and Gyna hospital in Al Shifa 
medical complex has 14 delivery rooms, there are a total of 1500 deliveries in this hospital 
(400 CS and 1100 normal vaginal delivery). Al Emaraty Crescent hospital is a specialized 
hospital of gynecology and obstetrics services, the clinical capacity of about 40 beds, 
located in the Tel Sultan-Rafah, built in the year 2000 on an area of 4000 m
2
, and serves 
the segment of the population living in the Rafah governorate with a population of 173,372 
(MoH, 2016). 
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Chapter 2: Conceptual Framework and Literature Review 
2.1 Introduction  
Every patient with pain has the right to be treated with dignity, respect, and high quality 
pain management (Olivier, et al., 2012). The nursing profession is dedicated to the 
provision of comfort and alleviation of suffering (Todd, et al., 2007). The American Pain 
Society (2010) supports efforts to improve pain management for patients in all healthcare 
settings. The Joint Commission implemented standards in 2000 requiring healthcare 
professionals to recognize the right of patients to have appropriate assessment and 
management of pain. All patients must be screened for pain on admission and re-assessed 
as clinically required throughout the hospital stay (The Joint Commission, 2015). The 
following section illustrates the conceptual framework of the study. 
2.2 Conceptual Framework 
 
Figure 2.1: Conceptual Framework of the Study (developed by the researcher) 
Knowedge and 
attitude of health 
care providers of 
medicating 
pregnanat women 
with chronic pain 
Experience 
Gender 
Working 
setting 
Educational 
qualifiction 
Job title 
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Figure 2.1 illustrates the conceptual framework for this study. The figure shows that there 
are six domains in the framework. The upper five domains are considered as the 
independent variables for this study, they are the factors which affect the knowledge and 
attitude of HCPs of medicating pregnant women with chronic pain, these domains include 
demographic factors such as: HCPs' gender, HCPs' ages, experience, titles, educational 
qualifications and working settings. The second domain is considered as dependent 
variable which is the knowledge and attitude of HCPs of medicating pregnant women with 
chronic pain. 
2.2 Literature Review 
2.2.1 Epidemiology of Chronic Pain 
Pain is responsible for 14% of Medicare/ Medicaid expenditures. Zuccaro et al. (2012) 
state that 61% of the United States (US) population report experiencing chronic or 
recurrent pain. The report of Institute of Medicine (IoM) revealed in 2011 also that 100 
million adults in the United States suffer from significant and chronic pain. The care and 
treatment of this pain costs in excess of 635 billion dollars annually (Gaskin and Richard, 
2012). Chronic pain can be nociceptive, neuropathic or mixed. Chronic pain can lead to 
pathologic changes in the nervous system that cause an increased sensitivity to pain and a 
reduced response to analgesics (Zuccaro et al., 2012).  
Shah et al. (2015) state that physiologic pregnancy changes can precipitate or exacerbate 
painful conditions. Chronic pain in pregnancy may be caused by musculoskeletal pain, 
pelvic, abdominal, organ pain, and headaches (Shah et al., 2015). Seventy-one percent of 
pregnant women report significant chronic pain during pregnancy related to lumbar and 
pelvic girdle instability. Only 25% of these women reported receiving any treatment for 
pain. Many of these women reported that they were told that nothing could be done to help 
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(Pierce et al., 2012). A retrospective cohort study by Brown and Johnston (2013) which 
looked at pain in 580 women found that 14% reported significant chronic pain during 
pregnancy. The study also found that 50% of women reported pain related to 
musculoskeletal changes in pregnancy. In Palestine, however there are no studies available 
for the epidemiology of chronic pain, one study showed that chronic pain is prevalent 
among cancer patients and among the women with breast cancer (Abu Farha et al., 2017). 
2.3 Chronic pain during pregnancy 
Worldwide, chronic pain impacts over 100 million and is the most common cause of long-
lasting disability (Webmed, 2017). Conspicuously, women are more impacted by chronic 
pain disorders than men. Health care providers are frequently faced with the difficulties of 
managing chronic pain conditions that were present prior to, during, or after pregnancy. 
Pain thresholds in healthy women without chronic pain have been shown to increase 
throughout pregnancy peaking just prior to delivery (Ray-Griffith et al., 2018). Animal 
models have shown that naltrexone, an opioid antagonist, can block these findings. It is 
unclear how these findings may translate to women with chronic pain or opioid exposure 
as such individuals often have hyperanalgesia, allodynia, and/or decreased pain thresholds 
at baseline (Ray-Griffith et al., 2018). 
Health care providers caring for obstetrical patients have inadequate training and limited 
time to manage patients with chronic pain. Pain management teams and clinics often 
discharge or decline to manage women during pregnancy, and transition of care is often 
referred to the obstetrical team. The lack of evidence-based treatment guidelines and 
limited formal training and expertise in the management of chronic pain places pregnant 
women at risk to receive suboptimal care. The majority of published reviews have focused 
on the pharmacological or non-pharmacological approaches, rather than on a broader scope 
of how to approach chronic pain during pregnancy (Dorheim et al., 2012). 
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2.4 Management of Chronic Pain in Pregnancy 
Pregnant women with chronic pain diagnoses present a unique challenge for obstetric care 
providers. Some present for prenatal care with pain related to prior injuries, surgeries, or 
other causes, and they are already taking opioid analgesics for episodic or continuous 
treatment. Others have pain issues that develop during pregnancy or are exacerbated by 
pregnancy and need to take opioid analgesics while pregnant to manage their conditions 
(Kellogg et al., 2011; Kennedy, 2011). Failure to adequately treat pain can have a negative 
effect on maternal health, resulting in depression, anxiety, and physical manifestations 
such as hypertension (Babb et al., 2010; Kennedy, 2011). As the use of analgesics and 
other medications for pain becomes more common and acceptable in pregnancy, it is 
necessary for obstetric care providers to be knowledgeable as to their safe use to manage 
maternal pain with the lowest risk for harmful effects on the mother, fetus, and neonate 
(Kellogg et al., 2011). 
There are different pain management techniques. Suggested pain management techniques 
included prevention of pain through exercise, positioning and physical therapy. If these 
techniques were not effective to prevent or manage pain, non-pharmacologic 
complementary and alternative treatments such as acupuncture, manipulation, and 
transcutaneous nerve stimulation were suggested. Acetaminophen was suggested as the 
drug of choice for severe pain (Shah et al., 2015). Non-steroidal anti-inflammatory agents 
such as ibuprofen and naproxen have been associated with premature closure of the fetal 
ductus arteriosus and vasoconstriction of maternal uterine arteries (Shah et al., 2015). The 
most commonly prescribed opiate analgesics in pregnancy are codeine, fentanyl, 
hydrocodone, morphine, oxycodone, oxycontin, and tramadol (Broussard et al., 2011). 
Total daily opioid dose to achieve adequate pain control may increase as pregnancy 
progresses and, therefore, pain moderators may be helpful. Adjunctive therapy with 
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amitriptyline 51mg to 100 mg at night, gabapentin 300 mg every 8 hours, and physical 
therapy to maintain and improve mobility are useful in individual cases, Ideally, women 
would be advised to wean to the lowest effective dose in the final weeks of pregnancy that 
will likely reduce the occurrence of NAS. (Nocon, 2013). 
For this reason, the uses of non-steroidal anti-inflammatory medications are 
contraindicated for chronic pain management during pregnancy. Previous studies posit that 
opioids should be used only in cases of severe and unrelenting pain but must be measured 
against the potential harm to the fetus. The authors expressed concern that the use of 
opioids could increase the risk of birth defects and that chronic use of opioids could lead to 
neonatal abstinence syndrome or newborn withdrawal (Shah et al., 2015). 
Pritham and McKay (2014) state in their review article on the management of chronic pain 
in pregnancy that failure to treat pain can have a negative impact on maternal health 
including hypertension, depression, and anxiety. The authors point out that the lack of a 
well-designed medication study is related to the ethical difficulties of conducting research 
in the pregnant population. 
A study of Ray-Griffith et al. (2018) was conducted to identify evidence-based clinical 
research for the evaluation and management of preexisting chronic pain in pregnancy, 
chronic pain associated with pregnancy, and chronic pain in relation to mode of delivery. 
The researchers searched a literature using search engines PubMed, CINAHL, 
EBSCOhost, and Web of Science.  
The study results revealed that the basis of this review was the 144 articles that met 
inclusion criteria for this review. Based on their review of the current literature, the 
researchers recommend 7 guidelines for chronic pain management during and after 
pregnancy: 1) complete history and physical examination; 2) monitor patients for alcohol, 
nicotine, and substance use; 3)  
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collaborate with patient to set treatment goals; 4) develop a management plan; 5) for 
opioids, use lowest effective dose; 6) formulate a pain management plan for labor and 
delivery; and 7) discuss reproductive health with women with chronic pain. 
Ray-Griffith et al. (2018) concluded that the management of chronic pain associated with 
pregnancy is not adequately studied. Some general guidelines are provided for those health 
care providers until more information is available. 
Persson et al. (2013) conducted a qualitative study of nine women experiencing severe 
chronic pain during pregnancy. The first theme was grasping the incomprehensible idea 
that severe and chronic pelvic girdle pain could be experienced related to a normal event 
such as pregnancy. The study participants were shocked to find that pain could lead to such 
significant life changes including a negative impact on sexual function and ability to sleep. 
The second theme focused on balancing support and dependence. Each of the study 
participants was unable to work and was placed on full time disability. The study 
participants had to request and accept assistance for normal activities of daily living. Study 
participants identified that they were unable to care for their existing children because of 
the pain they were experiencing. Elden et al. (2013) also conducted a qualitative study of 
27 women experiencing chronic pain in pregnancy. This study found that 20 – 23% of 
pregnant women had to take sick leave during pregnancy due to chronic pain. Themes 
identified in this study included the impact of pain on social life, partner relationships, 
inability to cope with activities of daily life and motherhood. 
Edmonds et al. (2017) conducted a self-administered survey to describe obstetrical 
providers‘ management of a hypothetical case on chronic pain in pregnancy and determine 
whether practices differ based on patient race. Seventy-six obstetrician-gynecologists and 
one nurse practitioner were surveyed. A case-vignette described a pregnant patient 
presenting with worsening chronic lower back pain, requesting an opioid refill and 
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increased dosage. Health care providers indicated their likelihood of prescribing opioids, 
drug testing, and referring on a 0 (definitely would not) to 10 (definitely would) scale; 
rated their suspicions/ concerns about the patient on a 0–10 VAS scale; and ranked those 
concerns in order of importance. The study results revealed that health care providers were 
not inclined to refill the opioid prescription or increase the dose. They were more likely to 
conduct urine drug tests on white than black patients and more likely to suspect that white 
patients would divert the medication. For white patients, providers‘ highest-ranked concern 
was the patient‘s risk of abuse/addiction, whereas, for black patients, it was harm to the 
fetus. Suspicion about symptom exaggeration was more closely related to decisions about 
refilling the opioid prescriptions and increasing the dose for black patients, whereas these 
decisions were more closely correlated with concerns about overdose for white patients. 
The study concluded that health care provider suspicion and concerns may differ by patient 
race, which may relate to differences in pain treatment and testing. 
2.4.1 Use of Analgesics in Pregnancy 
Kennedy (2011) estimated that as many as 85% of pregnant women use some type of 
medication during pregnancy, and that analgesics are the most commonly ingested after 
vitamins and supplements. The exact prevalence of recommended or prescribed analgesics 
in pregnancy is difficult to determine, but from available reports their worldwide use 
appears to be steadily increasing even though many are classified as pregnancy category B 
or C by the U.S. Food and Drug Administration (FDA) (Briggs et al., 2011). In the United 
States, 20% of pregnant women reported first-trimester opioid use in 2009. Among 
Tennessee Medicaid insured pregnant women, use of opioid analgesics increased nearly 2 
fold from 1995 to 2009 (Epstein et al., 2013). Furthermore, in a population based cohort 
study of 194,937 singleton pregnancies in Norway between March 2004 and January 2009, 
about 6% of the women were dispensed opioid analgesics before, during, or after 
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pregnancy. Most of the women were prescribed a weak short-acting opioid such as codeine 
in combination with paracetamol (acetaminophen) and less was dispensed after pregnancy 
was diagnosed. A small group of women took codeine throughout their pregnancies 
(Handal et al., 2011). 
2.4.2 Opioid Analgesics 
Opioid analgesics are becoming more commonly prescribed as awareness of chronic pain 
in pregnancy increases and as retrospective studies begin to demonstrate safety profiles 
(Hadi et al., 2006). One of the biggest risks of chronic opioid that was used during and 
outside of pregnancy is dependence, which often leads to misuse and abuse (Babb et al., 
2010). As these medications are more widely available, abuse potential is higher. For 
example, Kelly et al. (2011) reported an increase in oxycodone consumption from 8.4% to 
17.2% over an 18-month period during which their study of narcotic abuse in pregnancy 
was being conducted. For many years, the opiate class of drugs appeared to have a 
relatively low-risk profile for the neonate with little evidence for increased prevalence of 
major congenital anomalies and reassuring studies of neuro-developmental characteristics 
of exposed children after the initial newborn period (Babb et al., 2010; Malek and 
Mattison, 2011).  
However, more recent researchers have found an association between opiate use prior to 
conception and in the first trimester and birth defects (Broussard et al., 2011); therefore, 
use in women at risk of becoming pregnant or in early pregnancy should be undertaken 
cautiously (Brennan and Rayburn, 2012). The prevalence of neural tube defects in 
offspring of mothers who used opioids was estimated to be six per 10,000 live births 
(Yazdy et al., 2013). Women who are considering pregnancy while taking opiates will 
need to be advised to take at least 1 mg of folic acid daily to reduce the risk of fetal neural 
tube defects and to continue with folic acid supplementation while pregnant (Yazdy et al., 
17 
 
2013). Another risk of maternal use of opioids for chronic pain during pregnancy is that the 
exposed fetus is likely to experience neonatal abstinence syndrome (NAS), with an 
estimated overall rate of 5.6% (Kellogg et al., 2011). 
To minimize the adverse risks of opioid use in pregnancy and provide adequate maternal 
pain control, many factors must be considered when initiating or adjusting dosing of opioid 
analgesics in pregnancy. Genetic factors can affect metabolism and either decrease efficacy 
or increase the rate of conversion to active metabolites (Madadi et al., 2012). Drug 
absorption may be affected by decreased gastrointestinal motility, emesis, and 
gastroesophageal reflux (Wunsch et al., 2003). Additionally, there is an increase in 
cutaneous blood flow, an alteration of distribution in the maternal compartment, and the 
possibility of effects on drug absorption due to placental and fetal factors (Kennedy, 2011). 
Opioid receptors also play a part in the dosing of opioid analgesics in pregnancy. Most 
agents are lipophilic and bind to mu receptors as agonists; therefore, they cross the 
placenta rapidly and are readily available. For this reason, extended-release agents may not 
be as effective in pregnancy and have the potential to accumulate in the placental or fetal 
compartments (Malek & Mattison, 2011). 
2.4.3 Atypical narcotic-like analgesics 
Tramadol is reported in several individual case studies and one small prospective study. 
There appeared to be an increase in the incidence of spontaneous abortion with the use of 
tramadol, but no increase in congenital anomalies (Bloor et al., 2012). All of the case 
studies demonstrated an association with neonatal abstinence syndrome (in tramadol users 
(Bloor et al., 2012; Hartenstein et al., 2010; Willaschek et al., 2009). 
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2.5 Health care providers’ knowledge and attitude toward pain management 
Pregnant women are often denied adequate pain management because the care giver's 
belief system says that the pregnant woman's pain is not as important as the potential harm 
to the fetus (Vermani et al., 2009; Lupton, 2011; Lupton, 2012). Chronic opioid use in 
pregnancy is associated with birth defects such as spinal cord defects and cardiac defects 
(Broussard et al., 2011) and newborn withdrawal also known as Neonatal Abstinence 
Syndrome (Kellogg et al., 2011). Because of fear about use of drugs during pregnancy. 
Pregnant women are at risk of under treatment, or no treatment, for painful conditions 
(Babb et al., 2010). Shah et al. (2015) suggest that education, exercise and complementary 
medicine should be used prior to any medication for pain in pregnancy, and that women 
should ―understand that complete relief may not be possible until after delivery. 
Research studies indicated that pain continues to be inadequately treated by healthcare 
providers due to a combination of inadequate knowledge about pain, negative attitudes, 
poor ability to assess pain, fear of patient addiction, and restrictive regulation of controlled 
substances (Zuccaro et al, 2012). Research has identified that healthcare providers report 
inadequate education and a lack of experience with pain and pain management (Barry, et 
al., 2010). Grieves and Schultewolter (2014) state that pain has not been addressed in 
medical education and 52.0% of respondents in a National Pain Audit Report admitted to 
having difficulty understanding chronic pain.  
The Trust for America‘s Health (2015) has recommended that all health care providers 
should be educated to understand the risks and signs of opioid misuse. Healthcare 
providers have expressed frustration at the absence of objective or physiological measures 
of pain (Zuccaro et al., 2012). Physicians have been found to underestimate pain for female 
patients (Anderson, et al., 2000). Eagan and Cornally (2013) found that healthcare 
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providers had difficulty believing patient reports of pain when it did not match the 
observed non-verbal behavior. The IoM (2011) has identified provider attitude as an 
impediment to high quality pain care. Physicians have expressed concern about the 
potential for addiction, misuse and the legal ramifications of prescribing long term opioid 
medications (Zuccaro et al., 2012). Nurses have also expressed fear that administration of 
opioids for pain might encourage addiction (Morgan, 2014). The chronic use of opioids for 
pain has been increasing for the past two decades (Zuccaro et al., 2012).  
The attitude of the health care provider toward a patient with a history of opioid use is one 
of the factors that influence the administration of pain medication (Morgan, 2014). Health 
care professionals have been found to have negative attitudes toward patients with 
substance use disorders in all areas of medical care. These patients are less likely to receive 
adequate pain management (Morgan, 2006). 
A study conducted by Mellin (2016) to determine if perinatal nurses‘ intent to medicate 
pregnant women with chronic pain was affected by knowledge of pain, attitude, or 
demographics. The researcher explored the theoretical application of Ajzen‘s theory of 
planned behavior which suggests that attitude correlates with intention to act. The study 
adopted a quantitative, cross-sectional correlation using a survey to measure knowledge 
about pain, attitudes, and intent to medicate pregnant women with chronic pain. One 
hundred perinatal nurses who worked in labor and delivery, mother baby, or the neonatal 
intensive care unit from four hospitals in northern New Jersey participated in the study. 
Each hospital provided a different level of perinatal care from community basic, to 
intermediate, intensive, and regional perinatal center. The study results revealed that 
increased levels of education positively impact perinatal nurses‘ knowledge of pain, 
attitude of medicating pregnant women with chronic pain. The perinatal nurse‘s intent to 
medicate was not statistically correlated to age, years of nursing experience, or level of 
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perinatal care. Also, the perinatal nurse‘s intent to medicate a pregnant woman with 
chronic pain is positively correlated to increased knowledge of pain. Moreover, the attitude 
scores were positively correlated with an increased intent to medicate a pregnant woman 
with chronic pain. 
2.6 Ethical implications of untreated pain 
Faria da Cunha (2015) discussed the ethical implications of untreated pain in her article, 
―Ethics and under treatment of pain in patients with a history of drug abuse.‖ Faria da 
Cunha points out those patients taking chronic opioids for pain will develop opioid 
dependence which should not be confused with addiction. The author posits that 
―unrelieved pain is a form of suffering,‖. Faria da Cunha states that not treating pain 
violates the ethical principle of non-malficence which requires nurses to do no harm. It is 
further stated that the ethical principle of beneficence requires that nurses prevent harm 
and provide benefit. The adequate management of pain would be required by the principle 
of beneficence. Untreated and undertreated pain violates the ethical principle of autonomy 
because patients in pain are unable to make adequate judgments about care. The ethical 
principle of justice requires that all patients be treated fairly and equally. To deny adequate 
pain management to a patient based on the fact that she is pregnant or has a history of 
substance abuse violates the principle of justice (Faria da Cunha, 2015). 
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Chapter 3: Materials and Methods 
3.1 Introduction 
The chapter of materials and methods illustrates the issues related to materials, methods, 
and procedures which are supposed to be conducted in this study.  
3.2 Study design 
The design of this study was observational descriptive cross-sectional. This type of design 
was chosen because it's suitable in terms of people, resources and it is relatively practical 
and manageable.  
3.3 Study setting 
This study was carried out at governmental hospitals in the Gaza Strip which have obstetric 
departments, they are:  NMC, Al Aqsa Hospital, Al Shifa Medical Complex, and Al 
Emaraty Hospital. 
3.4 Study population 
The target population of this study consisted of HCPs such as physicians, nurses, 
midwives, and pharmacists who are working in the obstetric departments of the above-
mentioned hospitals. The total number of HCPs is 340 (MoH, 2017). 
3.5 Study period 
The study took months to be conducted as it started on March 2018 completed by October 
2018.  
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3.6 Sample and sampling Process 
 A simple random sample design was used in the current study, to select the study 
population. Sample calculated using Epi info version 7 based on the total number of above 
mentioned population. The calculated sample was 144 HCPs. 
3.7 Response rate 
In the current study, 136 HCPs out of 144 agreed to participate to fill up the questionnaire 
(response rate is 94.4%). 
3.8 Eligibility criteria  
3.8.1 Inclusion criteria  
- The HCPs such as physicians, nurses, midwives, and pharmacists who are working in 
the obstetric departments  
- Willing to participate in this study. 
3.8.2 Exclusion criteria  
- Volunteer HCPs. 
- Working for less than 6 months. 
 
3.9 Instrument of the study 
The researcher used an adapted self-administered survey in this study (Annex 3). This 
survey measures attitude, knowledge of HCPs of medicating pregnant women with chronic 
pain. This survey was adapted after come modifications from Ferrell and McCaffery 
(2014). This survey consists of combinations of case presentation of a pregnant woman 
23 
 
with a history of chronic pain. The survey tool has 31 items which includes a combination 
of true - false and multiple-choice questions, in addition to the demographic factors of the 
about HCPs including age, years of experience, and educational qualification. The first 17 
questions represent knowledge of pain; the following 14 questions represent attitudes of 
the HCPs toward pain. The questionnaire answers‘ were obtained from the original author. 
Each participant has had a knowledge score, and an attitude score. Each question was 
given a score of ―1‖ for the correct answer, and a positive attitude. On the other hand, a 
score of ―0‖ was given to incorrect answer, and negative attitude. Higher scores of HCPs 
indicated increased knowledge of chronic pain. The higher the attitude score, the more 
positive a HCPs attitude toward the medicating pregnant woman. (Annex 3). 
3.10 Data collection 
After obtaining MoH, Helsinki and university approval and the participating hospitals 
approval see annex (1).  
The researcher requested permission from the hospitals managers to meet with targeted 
HCPs on the identified departments each HCP was signed consent form. Participation was 
voluntary. The result will be added to knowledge regarding HCPs attitude toward pregnant 
women with chronic pain. The questionnaire took approximately 15 minutes to complete 
were no anticipated risk to participate in the study. 
3.11 Pilot study 
Pilot study was conducted done a sample of 10 HCPs. Content validity has been 
established by the review of panel of experts. Construct validity was established by 
comparing scores of nurses at numerous expertise levels, such as students, new graduates, 
graduate students, and senior pain experts. Test-retest reliability was established (r>.80) by 
repeat testing in a continuing education class involving 10 HCPs.  Internal consistency 
reliability was established as measured by Cronbach‘s alpha (alpha r > 0.70).   
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3.12 Scientific rigor 
3.12.1 Validity  
3.12.1.1 Face validity  
Self-administered questionnaire was organized in order to allow smooth data collection.  
3.12.1.1 Content validity  
Concerning the content validity, adequate reviewing of related topics in the literature about 
medicating pregnant women by HCPs.  To assess the relevant of the questionnaire aspects 
conducted evaluation process and comment were taken in consideration. In addition, a pilot 
study was conducted and slight modifications were done to make it well understood. This 
would increase the validity of the questionnaire. 
3.12.2 Reliability  
The following steps were done to assure instrument reliability:  
- Standardization of filling the questionnaire.  
- Data entry was done in the same of data collection to permit intervention to assure 
data quality and to refill the questionnaire when it is required.  
- Cronbach‘s alpha coefficient to check the reliability for each domain. 
- Test-retest reliability was established (r > 0.80). 
- Internal consistency reliability was established as measured by Cronbach‘s alpha 
coefficient (alpha r > 0.70). 
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3.13 Data entry and Statistical analysis 
The researcher used the statistical package for Social Science (SPSS) version 22. For 
statistical procedures and methods. Statistical tests included descriptive statistics such as 
frequencies and percentages, and inferential statistics such as independent sample t test, 
and One-Way ANOVA. 
3.14 Ethical and administrative consideration  
Administrative approval was obtained from Al-Quds University. Ethical approval was 
obtained from Helsinki committee (Annex 1), ministry of health (Annex 2). Informed 
consent was obtained from all of the HCPs to participate in the study. 
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Chapter 4 Results and Discussion 
4.1 Introduction 
This chapter illustrates the results of statistical analysis of data, including descriptive 
analysis that presents the socio - demographic characteristics of the study sample and 
answers to the study questions. The researcher used simple statistics including frequencies, 
means and percentages, also independent sample t test, and One-way ANOVA. 
4.2 Socio-demographic characteristics of the sample 
4.2.1 Sample distribution according to the participants’ gender, place of work, and 
their job titles  
Table 4.1: Sample distribution according to the participants’ gender, place of work, 
and their job titles (n=136) 
Variables Number Percentage (%) 
Gender 
Male 31 22.8 
Female 105 77.2 
Place of work 
Nasser Medical Complex 30 22.1 
Al Aqsa Hospital 24 17.6 
Al Shifa Medical Complex 65 47.8 
Al Emaraty Hospital 17 12.5 
Job title 
Nurse 9 6.6 
Midwife 55 40.4 
Physician 54 39.7 
Pharmacists 18 13.2 
 Total 136 100.0 
 
Table (4.1) shows the distribution of study participants‘ according to the participants‘ 
gender, place of work, and their job title. The table shows that the majority (77.2%) of the 
study participants are females, while 22.8% are males. The table also shows that 65 
(47.8%) of the study participants are working at Al Shifa Medical Complex, 30 (22.1%) 
are working at NMC, 24 (17.6%) are working at Al Aqsa Hospital. 
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Moreover, the table shows that 55 (40.4%) of the study participants are midwives, 5 
(39.7%) are physicians, 9 (6.6%) are nurses, while the pharmacists (13.2%). 
4.2.2 Sample distribution according to the educational level of participants 
 
Figure 4.1: Sample distribution according to the participants' educational level  
Figure (4.1) shows that 85 (62.5%) of the study participants have diploma education, 40 
(29.4%) have bachelor degree, and only 11 (8.1%) have post-graduate degrees such as 
master, Board, and Doctor of Philosophy. 
 
 
 
 
 
 
62.50% 
29.40% 
8.10% 
Diploma
Bachelor
Post-Graduate studies
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4.2.3 Sample distribution according to the participants’ age groups 
 
Figure 4.2: Sample distribution according to the participants’ age groups 
Figure (4.2) shows that 44.1% of the study participants are belonging to the age group 30 – 
40 years, 35.3% of them are more than 40 years, while 20.6% are below 30 years old 
4.2.4 Sample distribution according to the participants’ years of experience 
 
Figure 4.3: Sample distribution according to the participants’ years of experience 
35.30% 
44.10% 
20.60% 
More than 40 years30-40 yearsBelow 30 years
19.10% 
26.50% 
27.20% 
27.20% 
1 - 5 years
6 - 10 years
11 - 15 years
More than 15
years
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Figure(4.3) shows that 27.2% of the study participants have more than 5 years of 
experience with the same percentage have 11 – 15 years of experience, 26.5% of them 
have 6 – 10 years of experience, and 19.1% have 1 – 5 years of experience. 
4.3 Knowledge and Attitudes of the HCPs of Medicating Pregnant Women with 
Chronic Pain 
Table 4.2: Mean and Mean Percentage of Knowledge and Attitudes (n = 136) 
 
Maximum 
Mean Score 
Mean (SD) Mean Percentage 
Knowledge and Attitude 31.0 14.88 48.0 
Knowledge 19 10.47 (2.18) 55.14 
Attitude 12 4.36 (1.68) 36.33 
 
Table (4.2) shows that the mean and mean percentage of knowledge and attitudes of HCPs 
to medicate pregnant women with chronic pain. The maximum score of knowledge and 
attitude is 31.0 (100.0%). The maximum score of knowledge is 19.0 (100.0%), and the 
maximum score of attitudes is 12.0 (100.0%). The table shows that the mean of knowledge 
of HCPs is 10.47 out of 19 (55.14%), mean of their attitude is 4.36 out of 12 (36.33%), the 
total mean of knowledge and attitude is 14.88 out of 31.0 (48.0%). 
These results are not consistent with the results of Mellin (2016), which showed that the 
mean percentage of knowledge of HCPs regarding medicating pregnant women with 
chronic pain is 73.32%, and the mean of their attitude is 74.21%. The differences in the 
results between the current study and the study of Mellin could be attributed to the type of 
sample that have been recruited by Mellin, also it could be attributed to the main 
differences in the culture of HCPs in Palestine and European culture in terms of the issue 
of medicating pregnant women with chronic pain. In Palestine, most of HCPs are not 
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allowed to medicate any patient, and they are not allowed to prescribe any medication. 
Moreover, the nature of the questions that was introduced for the HCPs in the hospitals are 
not easy, require the HCP to study and make a revision for his/her information to very 
specific topics. 
 
4.4 Classifications of Knowledge and Attitudes of the HCPs of Medicating Pregnant 
Women with Chronic Pain 
Table 4.3: Classifications of Knowledge and Attitudes of the HCPs (n = 136) 
 Frequency % 
Knowledge and Attitude 
Negative Scores (<48.38
1
%) 57 41.9 
Positive Scores (≥48.38%) 79 58.1 
Knowledge 
Inadequate (<57.89%) 64 47.1 
Adequate (≥57.89%) 72 52.9 
Attitude 
Negative Scores (<33.33%) 45 33.1 
Positive Scores (≥33.33%) 91 66.9 
Total  136 100.0 
 
Table (4.3) shows classifications of knowledge and attitudes of the HCPs of medicating 
pregnant women with chronic pain. More than half of HCPs have positive scores in 
knowledge, attitude, and knowledge and attitude. If we have a look on the above table, we 
would see that the positive scores for all three dimensions are more than the negative ones, 
meaning that the HCPs are thinking positively toward the management process. 
                                                 
1
 The median score of knowledge and attitude 
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The study of Mellin (2016) showed that only 25.0% of the study participants have had 
positive scores in the knowledge of medicating women with chronic pain, while there was 
31.0% of them have had positive attitude regarding medicating pregnant women with 
chronic pain. This could be attributed to the differences in the classifications system 
between the current study and the study of Mellin. Moreover, low level of knowledge 
regarding chronic pain management among pregnant women could be attributed to the lack 
of evidence-based treatment guidelines and limited formal training and expertise in the 
management of chronic pain which places pregnant women at risk to receive suboptimal 
care (Dorheim et al., 2012). On the other hand, these results are consistent with what have 
been introduced by Barry et al. (2010), in which their study revealed that research has 
identified that HCPs report inadequate education and a lack of experience with pain and 
pain management (Barry et al., 2010). Additionally, Grieves and Schultewolter (2014) 
stated that chronic pain has not been addressed in medical education and 52.0% of 
respondents in a National Pain Audit Report admitted to having difficulty understanding 
chronic pain. 
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4.5 Differences in the Knowledge and Attitudes of HCPs of Medicating Pregnant 
Women with Chronic Pain with Regard to their Demographic Factors 
Table 4.4: Differences in the Knowledge and Attitudes of HCPs of Medicating 
Pregnant Women with Chronic Pain with Regard to their Demographic Factors (n = 
136) 
Variable 
Mean (SD)  
t statistics (df) p value
*
 
Males Females 
Knowledge and 
Attitudes 
15.16 (3.76) 14.80 (2.44) 0.615 (134) 0.539 
Knowledge 10.45 (2.44) 10.48 (2.11) -0.076 (134) 0.940 
Attitudes 4.64 (2.25) 4.27 (1.47) 0.857 (37.88) 0.397 
*
Independent sample t test 
Table (4.4) shows that there are no statistically significant differences in the level of HCPs' 
knowledge and attitudes, HCPs 'knowledge, and HCPs 'attitudes between males and 
females (p> 0.05). Based on what was revealed in this study about the level of HCPs 
knowledge and attitude about chronic pain; this low level is cumulative since many years. 
Since the medical, nursing, and other health related colleges in the GS are not interested to 
conduct specific education about medicating chronic pain, thus the level of knowledge and 
attitude of them will not differ between males and females because they have unified 
curriculum either in medical, nursing, or any related field. 
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4.6 Differences in the Knowledge and Attitudes of HCPs of Medicating Pregnant 
Women with Chronic Pain among Different Age Groups 
Table 4.5 Differences in the Mean Knowledge and Attitudes of HCPs of Medicating 
Pregnant Women with Chronic Pain among Different Age Groups (n = 136) 
Variable N Mean (SD) F (df) P value
*
 
Knowledge and Attitudes 
Below 30 years  28 15.07 (2.95) 
0.513 (2, 133) 0.600 30 – 40 years 60 14.61 (2.64) 
More than 40 years 48 15.12 (2.89) 
Knowledge 
Below 30 years  28 10.14 (2.46) 
4.923 (2, 133) 0.009 30 – 40 years 60 10.01 (2.12) 
More than 40 years 48 11.25 (1.90) 
Attitudes 
Below 30 years  28 4.96 (1.95) 
2.408 (2, 133) 0.094 30 – 40 years 60 4.26 (1.53) 
More than 40 years 48 4.12 (1.64) 
*
One way ANOVA 
Table (4.5) shows that there are no statistically significant differences in the level of HCPs' 
knowledge and attitudes, and HCPs' attitudes among their different age groups (p>0.05). 
On the other hand, the table shows that there is a statistically significant difference in the 
level of HCPs' knowledge among their different age groups (p<0.05). Post hoc analysis 
was done using Scheffe test and shows that the difference is statistically significant among 
the age group (30 – 40 years) and the age group (more than 40 years) in favor of HCPs 
who are more than 40 years. This result is consistent with the result of Mellin (2016) which 
showed that there was a correlation between nurses' age and their knowledge of medicating 
chronic pain. 
In the current study, age played an important role in determining the HCPs' knowledge of 
medicating pregnant women with chronic pain, those who have more than 40 years; have 
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more knowledge score. This result could be attributed to the fact that age plays an 
important role in generating more experience especially in pain management among HCPs, 
however this was not revealed in the attitude level, and this could generate some fact about 
this results, in which knowledge and attitude are not totally closed together, it is not 
necessary to be correlated together. 
Absence of statistical significant difference in the attitude level among diferent age groups 
of HCPs could be attributed to the fact that pain has been studied among the studied 
sample, thus their attitude has been specified, and this what has been supported by Grieves 
and Schultewolter (2014) in which they proved state that pain has not been addressed in 
medical education and 52.0% of respondents in their study a admitted to having difficulty 
understanding chronic pain.  
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4.7 Differences in the Knowledge and Attitudes of medicating Pregnant Women with 
Chronic Pain among Different Educational Levels 
Table 4.6: Differences in the Mean Knowledge and Attitudes of Medicating Pregnant 
Women with Chronic Pain among Different Educational Levels (n = 136) 
Variable N Mean (SD) F (df) P value
*
 
Knowledge and Attitudes 
Diploma 85 14.81 (2.59) 
1.025 (2, 133) 0.362 Bachelor 40 15.30 (3.25) 
Post-graduate Studies 11 14.00 (2.36) 
Knowledge 
Diploma 85 10.42 (2.20) 
0.894 (2, 133) 0.411 Bachelor 40 10.77 (2.14) 
Post-graduate Studies 11 9.81 (2.27) 
Attitudes 
Diploma 85 4.50 (1.59) 
1.069 (2, 133) 0.346 Bachelor 40 4.20 (1.93) 
Post-graduate Studies 11 3.81 (1.32) 
*
One way ANOVA 
Table (4.6) shows that there are no statistically significant differences in the level of HCPs' 
knowledge and attitudes, HCPs' knowledge, and HCPs' attitudes among their different 
educational levels (p> 0.05). The results revealed no statistically significant differences 
among educational level of HCPs, this could be attributed and support the above-
mentioned results in which Grieves and Schultewolter (2014) stated that chronic pain has 
not been addressed in medical education and 52.0% of respondents in a national pain audit 
report admitted to having difficulty understanding chronic pain. So, because it was not 
addressed within Gaza Universities, there will be no differences with regard to educational 
level of HCPs. 
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On the other hand, these results are not consistent with the results of Mellin (2016) which 
revealed that increased levels of education positively impact perinatal nurses‘ knowledge 
of pain, attitude of medicating pregnant women with chronic pain. 
Also, to the best or researcher‘s knowledge, all of health care providers understand pain as 
a medical problem, it is not affected by their educational level, and this issue is a matter of 
humanity, not merely a medical or professional one. 
4.8 Differences in the Knowledge and Attitudes of Medicating Pregnant Women with 
Chronic Pain among Job Titles 
Table 4.7: Differences in the Mean Knowledge and Attitudes of Medicating Pregnant 
Women with Chronic Pain among Job Titles (n = 136) 
Variable N Mean (SD) F (df) P value
*
 
Knowledge and Attitudes 
Nurse 9 15.33 (2.00) 
1.106 (3, 132) 0.349 
Midwife 55 14.38 (2.81) 
Physician 54 15.31 (2.98) 
Pharmacists 18 14.94 (2.31) 
Knowledge 
Nurse 9 11.66 (1.50) 
2.019 (3, 132) 0.114 
Midwife 55 10.01 (2.24) 
Physician 54 10.61 (2.21) 
Pharmacists 18 10.88 (1.99) 
Attitudes 
Nurse 9 3.66 (1.00) 
1.190 (3, 132) 0.316 
Midwife 55 4.25 (1.37) 
Physician 54 4.64 (1.98) 
Pharmacists 18 4.16 (1.79) 
*
One way ANOVA 
Table (4.7) shows that there are no statistically significant differences in the level of HCPs' 
knowledge and attitudes, HCPs' knowledge, and HCPs' attitudes among their different job 
titles (p> 0.05). This result could be attributed to the number of studied sample, in which 
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nearly half of participants are nurses and midwives, and the issue of prescribing pain 
medications is not from the responsibilities of nurses and midwives in the ministry of 
health in the GS. So, to specify the attitude of health care providers, they have to engage in 
this experience; thus the nurses and midwives did not engage in that experience and work, 
and this what has been supported by Zuccaro et al. (2012) in which their study revealed 
that the physicians have expressed concern about the potential for addiction, misuse and 
the legal ramifications of prescribing long term opioid medications, but Morgan (2014) 
revealed that the nurses have expressed fear that administration of opioids for pain might 
encourage addiction.  
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4.9 Differences in the Mean of Knowledge and Attitudes of Medicating Pregnant 
Women with Chronic Pain among Different Years of Experience 
Table 4.8: Differences in the Mean of Knowledge and Attitudes of Medicating 
Pregnant Women with Chronic Pain among Different Years of Experience (n = 136) 
Variable N Mean (SD) F (df) P value
*
 
Knowledge and Attitudes 
1 – 5 years 26 15.46 (2.65) 
1.416 (3, 132) 0.241 
6 – 10 years 36 14.11 (2.57) 
11 – 15 years 37 15.10 (3.54) 
More than 15 years 37 15.02 (2.08) 
Knowledge 
1 – 5 years 26 10.15 (2.36) 
4.094 (3, 132) 0.008 
6 – 10 years 36 10.00 (2.07) 
11 – 15 years 37 10.13 (2.50) 
More than 15 years 37 11.51 (1.44) 
Attitudes 
1 – 5 years 26 5.19 (1.81) 
4.426 (3, 132) 0.005 
6 – 10 years 36 4.05 (1.67) 
11 – 15 years 37 4.62 (1.76) 
More than 15 years 37 3.81 (1.24) 
*
One way ANOVA 
Table (4.8) shows that there are no statistically significant differences in the level of HCPs' 
knowledge and attitudes among their different years of experience (p> 0.05). On the other 
hand, the table shows that there is a statistically significant difference in the level of HCPs' 
knowledge among their different years of experience (p <0.05). Post hoc analysis was done 
using Scheffe test and shows that the difference was statistically significant among HCPs 
with 6 – 10 years of experience and who have more than 15 years of experience in favor of 
HCPs who have more than 15 years of experience. 
Additionally, there is a statistically significant difference in the level of HCPs' attitudes 
among their different years of experience (p <0.05). Post hoc analysis was done using 
Scheffe test and showed that the difference is statistically significant among HCPs with 1 – 
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5 years of experience and who have more than 15 years of experience in favor of HCPs 
who have 1 – 5 years of experience. 
These results are supported by the results obtained in the same chapter, in which HCPs 
have different mean knowledge score with regard to their ages, this could be attributed to 
the fact that the advancement in age; yield an advancement in experience. Moreover, these 
results are not consistent with the results of Mellin (2016) which revealed that perinatal 
nurses‘ intent to medicate was not statistically correlated to their years of nursing 
experience. 
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4.10 Differences in the Mean of Knowledge and Attitudes of Medicating Pregnant 
Women with Chronic Pain among Different Places of Work 
Table 4.9: Differences in the Mean of Knowledge and Attitudes of Medicating 
Pregnant Women with Chronic Pain among Different Places of Work (n = 136) 
Variable N Mean (SD) F (df) P value
*
 
Knowledge and Attitudes 
Nasser Medical Complex 30 14.53 (2.65) 
0.901 (3, 132) 0.443 
Al Aqsa Hospital 24 15.70 (2.57) 
Al Shifa Medical Complex 65 14.75 (3.54) 
Al Emaraty Hospital 17 14.88 (2.08) 
Knowledge 
Nasser Medical Complex 30 9.10 (2.33) 
5.716 (3, 132) <0.001 
Al Aqsa Hospital 24 10.83(1.52) 
Al Shifa Medical Complex 65 10.93 (2.06) 
Al Emaraty Hospital 17 10.64 (2.31) 
Attitudes 
Nasser Medical Complex 30 5.50 (2.25) 
8.387 (3, 132) <0.001 
Al Aqsa Hospital 24 4.54 (1.41) 
Al Shifa Medical Complex 65 3.78 (1.17) 
Al Emaraty Hospital 17 4.29 (1.57) 
*
One way ANOVA 
Table (4.9) shows that there are no statistically significant differences in the level HCPs' 
knowledge and attitudes among their different places of work (p >0.05). On the other hand, 
the table shows that there is a statistically significant difference in the level of HCPs' 
knowledge among their different places of work (p <0.05). Post hoc analysis was done 
using Scheffe test and shows that the difference is significant among HCPs who are 
working at NMC and who are working at Al Aqsa hospital in favor of those who are 
working at Al Aqsa hospital. Also, the difference is statistically significant among HCPs 
who are working at NMC and who are working at Al Shifa medical complex in favor of 
those who are working at Al Shifa medical complex. 
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Additionally, there is a statistically significant difference in the level of HCPs' attitudes 
among their different places of work (p <0.05). Post hoc analysis was done using Scheffe 
test and shows that the difference is statistically significant among HCPs who are working 
at NMC and who are working at Al Shifa medical complex in favor of those who are 
working at NMC. 
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Chapter 5 Conclusion and Recommendations 
5.1 Introduction 
In the following paragraphs, a brief conclusion which was drawn from the study results 
will be illustrated. Also, based on these conclusions, specific recommendations were made. 
5.2 Conclusion 
The main aim of this study was to investigate the level of knowledge and attitudes of HCPs 
regarding medicating pregnant women with chronic pain in the GS. The design of this 
study was observational descriptive cross-sectional. This study was carried out at 
governmental hospitals in the Gaza Strip which have obstetric departments, such as NMC, 
Al Aqsa Hospital, Al Shifa Medical Complex, and Al Emaraty Hospital. A simple random 
sample was used in the current study, in which all of HCPs who are working in the 
obstetric departments on the above-mentioned hospitals were selected to participate in the 
study. The researcher used self-administered survey in this study which was adopted after 
some modifications from Ferrell and McCaffery (2014).  
The study results showed that the mean of knowledge of HCPs is 10.47 out of 19 
(55.14%), mean of their attitude is 4.36 out of 12 (36.33%), and the total mean of 
knowledge and attitude is 14.88 out of 31.0 (84.0%). The study results also showed that the 
positive scores for all three dimensions are more than the negative ones, meaning that the 
HCPs are thinking positively toward the pain management process. Also, there is a 
statistically significant difference in the level of HCPs' knowledge among their different 
age groups in favor of the age group (30 – 40 years) and the age group (more than 40 
years) in favor of HCPs who are more than 40 years.  
43 
 
On the other hand, the results showed that there is a statistically significant difference in 
the level of HCPs' knowledge among their different years of experience. Additionally, 
there is a significant difference in the level of HCPs' attitudes among their different years 
of experience in favor of HCPs who have 1 – 5 years of experience. 
5.3 Implications for Practice 
Pregnant women with chronic pain have a right to effective pain management. The overall 
low knowledge and attitude scores reported by HCPs indicate that many pregnant women 
with chronic pain may not be receiving adequate pain management in the GS. The HCPs' 
attitude is likely to affect the women to obtain adequate pain relief. This project has 
revealed increased knowledge of pain is related to a more positive attitude toward pregnant 
women with chronic pain. More than 30.0% of HCPs did not have a positive attitude score 
toward pregnant women with chronic pain.  
The large percentage of HCPs who did not have a positive knowledge and / or attitude 
toward pregnant women with chronic pain may indicate similar concerns. These findings 
indicate a HCPs' knowledge about medicating pregnant women is influenced by the 
hospitals. Educational preparation is also associated with increased knowledge, and 
attitude scores. Educational programs designed to increase the knowledge of all HCPs 
regarding chronic pain may improve HCPs' knowledge and attitudes to medicate pregnant 
women with chronic pain. The development of health care practice guidelines in the care 
of pregnant women with chronic pain is also indicated. 
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5.4 Recommendations 
Based on the study results the researcher has the chance to make number of 
recommendations for improving the HCPs knowledge and attitude toward medicating 
pregnant women with chronic pain. These recommendations might help the HCPs‘ 
managers and policy maker to set priorities.  
5.4.1 Recommendations for policy makers 
Conducting periodic educational sessions for all types of HCPs to receive more important 
information about chronic pain management especially for pregnant women. Moreover, 
incorporating chronic pain management within medical, nursing, and other allied health 
sciences curriculum is considered cornerstone to start solving the current problem. 
Additionally, continuing assessment of HCPs is needed to facilitate organizing future 
sessions regarding providing in-service education and on-the job training chronic pain 
management. 
5.4.2 Recommendations for HCPs 
- Further studies are required in other departments and other types of patients.  
- This study should be replicated in other settings such as primary health care 
centers.  
- This study should be replicated on specific type of HCPs such as nurses or 
physicians. 
- Additional research is needed to confirm that an education program regarding pain 
and treatment of pain will increase HCPs' knowledge of pain, increase their attitude 
score to medicate a pregnant woman with chronic pain. 
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Annex 3: Consent form and Questionnaire 
- Consent form 
 
ميحرلا نمحرلا للها مسب 
 
Dear colleagues: 
Peace, mercy and blessings of God 
I have a special questionnaire for Master degree of Maternal and Child Health Program - 
Faculty of Health Professions, Al-Quds University, which I am currently conducting a 
thesis  entitled:  
Knowledge and Attitudes of Medicating Pregnant Women with Chronic Pain: A 
Survey of Health Care Providers in Gaza Governorates 
Please answer all questionnaires paragraphs as honestly as possible; your answer expresses 
your own opinion. The collected information will be used for research purposes only in 
order to ensure that all information will remain confidential, please do not include your 
name. 
  
 
 
 
 
 
Researcher 
Fatima Kamal El Din El Maghary 
Mobile / 0598663313 
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- Questionnaire 
Knowledge and Attitude of Medicating Pregnant Women with Chronic Pain 
Serial number ………… 
Section (1): Socio demographic data of health care providers 
  
 Age of health care provider      -------Years      
 Gender □ Male  □ Female    
 Years of experience  ……… years    
 Educational qualification □ Diploma □ Bachelor □ Master □ PhD 
□ University □ Higher studies  
 Title □ Nurse □ Midwife □ Physician 
□ Others, specify ……………………………….. 
 Hospital name ……………………………….. 
 Governorate ……………………………….. 
 
Part (2): Assessment of health care providers’ knowledge and attitudes toward 
chronic pain  
 
Put True Or False in front of the following sentences 
1.  Vital signs are always a reliable indicator of the intensity of a 
patient‘s pain. 
T F 
2.  Patients who can be distracted from pain usually do not have 
severe pain.  
T F 
3.  Patients may sleep in spite of severe pain.  T F 
4.  Respiratory depression rarely occurs in patients who have been 
receiving stable doses of opioids over a period of months 
T F 
5.  Combining analgesics that work by different mechanisms (e.g., 
combining NSAID with an opioid) may result in better pain 
control than using a single analgesic agent. 
T F 
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6.  The usual duration of analgesia of 1 -2 mg of morphine is 4 -5 
hours.  
T F 
7.  Patients should be encouraged to endure as much pain as 
possible before using an opioid. 
T F 
8.  Patients‘ spiritual beliefs may lead them to think pain and 
suffering are necessary. 
T F 
9.  After the initial dose of opioid analgesic is given, subsequent 
doses should adjusted in accordance with the individual patient‘s 
response. 
T F 
10.  Giving patients sterile water by injection (placebo) is a useful 
test to determine if the pain is real 
T F 
11.  If the source of the patient‘s pain is unknown, opioids should not 
be used during the pain evaluation period, as this could mask the 
ability to correctly diagnose the cause of pain 
T F 
12.  Anticonvulsant drugs such as gabapentin (Neurontin) produce 
optimal pain relief after a single dose 
T F 
13.  Benzodiazepines are not effective pain relievers and are rarely 
recommended as part of an analgesic regiment. 
T F 
14.  Narcotic/opioid addiction is defined as a chronic neurobiological 
disease, characterized by behaviors that include one or more of 
the following: impaired control over drug use, compulsive use, 
continued use despite harm, and craving. 
T F 
15.  The term ‗equianalgesia‘ means approximately equal analgesia 
and is used when referring to the doses of various analgesics that 
provide approximately the same amount of pain relief. 
T F 
16.  Sedation assessment is recommended during opioid pain 
management because sedation precedes opioid-induced 
respiratory depression. 
T F 
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17. The recommended route of administration of opioid analgesics for patients with 
persistent pain is: 
a. Intravenous     b. Intramuscular        c. Subcutaneous     d. Oral e. Rectal 
 
18. The recommended route of administration of opioid analgesics for patients with 
brief severe pain of chronic onset vs chronic pain: 
a. Intravenous            b. Intramuscular        c. Subcutaneous      d. Oral e. Rectal 
 
19. Which of the following analgesic medications is considered the drug of choice for 
the treatment of prolonged moderate to severe pain? 
a. Codeine        b. Morphine          c. Meperidine          d. Tramadol 
20. A 30 mg dose of oral morphine is approximately equivalent to: 
a. Morphine 5 mg IV 
b. Morphine 10 mg IV 
c. Morphine 30 mg IV 
d. Morphine 60 mg IV 
 
21. Analgesics for post-operative pain should initially be given: 
a. Around the clock on a fixed schedule 
b. Only when the patient asks for medication 
c. Only when the nurse determines that the patient has moderate or greater discomfort 
 
22. A patient with persistent pain has been receiving daily opioid analgesics for 2 
months. Yesterday the patient was receiving 200 mg/ hour intravenously. Today she 
has been receiving 250 mg hour intravenously. The likelihood of the patient clinically 
significant respiratory depression in the absences of a new comorbidity is: 
a. Less than 1% 
b. 1 -10% 
c. 11-20% 
d. 21 – 40% 
e. > 41% 
 
23. The most likely reason a patient with pain would request an increase dose of pain 
medication is: 
a. The patient is experiencing increased pain. 
b. The patient is experiencing anxiety or depression. 
c. The patient is requesting more staff attention. 
d. The patient‘s requests are related to addiction. 
 
24. The most accurate judge of the patient’s pain is: 
a. The treating physician.  b. The patient‘s primary nurse.  c. The patient. 
d. The pharmacist   e. The patient‘s spouse or family. 
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25. How likely it is that patients who develop pain already have an alcohol and /or 
drug abuse problem? 
a. Less than 1%  
b. 5 – 15 %  
c. 25-50%  
d. 75-100% 
 
26. The time to peak effect for morphine given IV is: 
a. 15 minutes 
b. 45 minutes 
c. 1 hour 
d. 2 hours 
 
27. The time to peak effect for morphine given orally is: 
a. 5 minutes 
b. 30 minutes 
c. 1 – 2 hours 
d. 3 hours 
 
28. Following abrupt discontinuation of an opioid, physical dependence is manifested 
by the following: 
a. Sweating, yawning, diarrhea, and agitation. 
b. Impaired control over drug use, compulsive use, and craving. 
c. The need for higher doses to achieve the same effect. 
d. a and b 
 
29. Which statement is true regarding opioid induced respiratory depression: 
a. More common several nights after surgery due to accumulation of opioid. 
b. Obstructive sleep apnea is an important risk factor. 
c. Occurs more frequently in those already on higher doses of opioids before surgery. 
d. Can be easily assessed using intermittent pulse oximetry. 
 
30. Patient A: Andrea is 25 years old, 25 weeks pregnant, and this is her first day after 
ureteral stent placement for chronic kidney stones. As you enter her room, she smiles 
at you and continues talking and joking with her visitor. Your assessment reveals the 
following information: BP = 120/80; HR = 80; R = 18; on a scale of 0 – 10 (0 = no pain, 
10 = worst pain) she rates her pain as an 8. On the patients record you mark her pain 
on the scale below. Circle the number that represents your assessment of Andrea’s 
pain. 
 
0 (no pain) 1 2 3 4 5 6 7 8 9 10 (Worst pain) 
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The pain assessment above is made two hours after she received morphine 2 mg IV. 
Thirty minute pain ratings following the injection range from 6 – 8 and she has had 
no respiratory depression, sedation, or other untoward side effects. Andrea has 
identified that 2/10 as an acceptable level of pain relief. The physician’s orders for 
analgesia allow you to administer morphine IV 1 mg every 1 hour PRN mild pain 
relief, morphine IV 2 mg every 1 hour PRN moderate pain relief, or morphine IV 3 
mg every 1 hour PRN severe pain relief. Circle the action that you will take at this 
time. 
a. Administer no morphine at this time.      b. Administer morphine 1 mg IV now. 
c. Administer morphine 2 mg IV now.        d. Administer morphine 3 mg IV now. 
 
 
Patient B: Rachel is 25 years old, 25 weeks pregnant, and this is her first day after 
ureteral stent placement for chronic kidney stones. As you enter her room, she is lying 
quietly and grimaces as she turns in bed. Your assessment reveals the following 
information: BP = 120/80; HR = 80; R = 18; on a scale of 0 – 10 (0 = no pain, 10 = 
worst pain) she rates her pain as an 8. 
On the patients record you circle her pain on the scale below. Circle the number that 
represents your assessment of Rachel’s pain. 
0 (no pain) 1 2 3 4 5 6 7 8 9 10 (Worst pain) 
 
The pain assessment above is made two hours after she received morphine 2 mg IV. 
Thirty minute pain ratings following the injection range from 6 – 8 and she has had 
no respiratory depression, sedation, or other untoward side effects. Rachel has 
identified that 2/10 as an acceptable level of pain relief. The physician’s orders for 
analgesia allow you to administer morphine IV 1 mg every 1 hour PRN mild pain 
relief, morphine IV 2 mg every 1 hour PRN moderate pain relief, or morphine IV 3 
mg every 1 hour PRN severe pain relief. Circle the action that you will take at this 
time. 
a. Administer no morphine at this time.     b. Administer morphine 1 mg IV now. 
c. Administer morphine 2 mg IV now.       d. Administer morphine 3 mg IV now. 
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Annex4: Control panel 
No Name Workplace 
1 Dr. Emad Fashafsha  American University – Jenin 
2 Dr. Suha Baalousha  Ministry of Health  
3 Mr. Adham ahmad KYTC – UNRWA 
4. Dr. Mohammad Tabash AlAzhar University 
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 مسيدات الحواملالمعرفة والاتجاىات حول علاج الألم المزمن لعنوان الدراسة: 
 المغاري.كمال الدين جبر فاطمة إعداد: 
 : د. أحمد نجم.إشراف
 ملخص:
وأن يتتم عتلاج الألتم ال تا/ بتوىا عمت   واحترام بكرامة يعامل أن في الحق الألم من يعاني مريض لكل
 الراحتتتة مستتتتوا عتتتالي متتتن الجتتتودمه و تتتد حظيتتتت مينتتتة التمتتتريض باىتمتتتام عتتتالي عمتتت  مستتتتوا  تتتوفير
ىدفت ىذه الدراسة إل  تقيتيم معرفتة المعانام لممرض  الذين يعانون من الألم المزمنه لقد  من والت فيف
 المواتي يعتانين متن ألتم متزمن الحوامل لمنساء يتعمق بعلاج الألم فيما الصحية الرعاية مقدمي واتجاىات
غتتزم الحكوميتتةه حيتتت اتبعتتت الباحاتتة متتنيو الملاحظتتة الوصتتفي لتحقيتتق أىتتداف   طتتاع فتتي مستيتتفيات
وايتتقت ىتذه  114باستت دام برنتامو إحصتائي ل  عينة عيوائيةو د تكون مجتمع الدراسة من الدراسةه 
 طاع الصحية الذين يعممون في أ سام الولادم في مستيفيات  الرعاية مقدميمن  310العينة من أصل 
ه و تتد استتتت دمت %1.14بنستتبة  للإجابتتة عمتتت  أدام الدراستتتة 304و تتد استتتتجا  متتنيم غتتتزم الحكوميتتة 
النستتت  المئويتتتة  ماتتتلحصتتتائية الإ الأستتتالي تتتم استتتت دام الباحاتتتة الاستتتتبانة كتتت دام لجمتتتع البيانتتتاته و تتتد 
 .تقمتينه وا تبار التباين الأحاديت لعينتين مسراوا تباالحسابيه وسط متوال
ال اصتة فيمتا ي ت/  الصتحية الرعايتة بتين مقتدميمعرفتة ال نستبة متوستط أن الدراستة ن تائو لقتد أظيترت
متوستط نستبة الاتجاىتات  وأن %ه14.22 ىتو المواتي يعانين من ألتم متزمن الحوامل علاج الألم لمنساء
كيتتتفت الن تتتائو أنتتتو لا توجتتد فتتتروق ذات دلالتتة إحصتتتائية فتتتي فقتتد  أ تتتراه ناحيتتتة %ه متتن00.30ىتتتي 
ه لجتتتتنسبتتتتالمتغيرات  افيمتتتتا يتعمتتتتق  لمقتتتتدمي الرعايتتتتة الصتتتتحيةموا تتتتف الو  تالمعرفتتتتة والاتجاىتتتتامستتتتتوا 
فرو تتات فتتي حتتين كانتتت ىنتتاك ). وأمتتاكن العمتتل هستتنوات ال بتترمه المقتت  التتوظيفيه المستتتويات التعميميتتة
يتة لصتال  فيمتا يتعمتق بفئتاتيم العمر متوستط المعرفتة لمقتدمي الرعايتة الصتحية فتي  ذات دلالتة إحصتائية
متوستط المعرفتة فتي  فرو تات ذات دلالتة إحصتائيةىنتاك أيضتًا فقتد كانتت  هعاًمتا 31متن ىتم أكاتر متن 
 24لتدييم أكاتر متن ستنوات  بترتيم الم تمفتة لصتال  أولئتك التذين بفيما يتعمتق لمقدمي الرعاية الصحية 
متوستط المعرفتة فتي  فرو تات ذات دلالتة إحصتائيةكانتت ىنتاك فقتد ه وعتلاوم عمت  ذلتكه سنة من ال بترم
 متاكن عمميتم الم تمفتة لصتال  أولئتك التذين يعممتون فتي مستيتف  بفيما يتعمتق الرعاية الصحية  لمقدمي
 الأ ص .
فيمتتا ي تت/ عتتلاج  الصتتحية الرعايتتة إلتت  أن ىنتتاك معرفتتة محتتدودم لتتدا مقتتدمي الدراستتة  مصتتت ن تتائو
قتتد بتترامو المتتواتي يعتتانين متتن ألتتم متتزمنه و تتد أوصتتت الباحاتتة بضتترورم ع الحوامتتل لمنستتاءالمتتزمن الألتتم 
 .لمنساء الحوامل في  طاع غزم المزمن تعميمية لمقدمي الرعاية الصحية فيما ي / علاج الألم
